| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.269 | 15.027 | - | 12.031 | 12.024 | 24.112 | 27.932 | 28.081 | 24.011 | 22.509 |
| Total Income - EUR | 18.270 | 15.299 | - | 12.216 | 12.090 | 24.425 | 29.487 | 28.083 | 24.074 | 22.513 |
| Total Expenses - EUR | 4.563 | 1.309 | - | 705 | 616 | 1.240 | 1.420 | 388 | 583 | 508 |
| Gross Profit/Loss - EUR | 13.708 | 13.990 | - | 11.510 | 11.474 | 23.186 | 28.067 | 27.696 | 23.491 | 22.005 |
| Net Profit/Loss - EUR | 13.160 | 13.538 | - | 11.149 | 11.114 | 22.513 | 27.232 | 26.870 | 19.808 | 18.555 |
| Employees | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharmalink Reprezentant Fiscal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 6 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 44.680 | 16.023 | - | 11.650 | 11.620 | 23.224 | 27.925 | 28.559 | 73.108 | 20.070 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.046 | 3.081 | - | 3.039 | 2.927 | 6.343 | 7.052 | 27.239 | 3.065 | 6.052 |
| Cash | 41.634 | 12.942 | - | 8.612 | 8.693 | 16.881 | 20.873 | 1.320 | 70.044 | 14.017 |
| Shareholders Funds | 44.592 | 13.992 | - | 11.665 | 11.619 | 23.009 | 27.717 | 27.357 | 20.293 | 19.037 |
| Social Capital | 67 | 445 | - | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 88 | 2.052 | - | 0 | 1 | 215 | 208 | 1.202 | 52.815 | 1.032 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Pharmalink Reprezentant Fiscal Srl